Patents/Assignees

Bristol-myers Squibb Company

249 patents in portfolio

US12466888utility2025
Methods of Treating Tumor
0 cites
US12459904utility2025
Process for Preparing Carbamoyloxymethyl Triazole Cyclohexyl Acid Compounds
0 cites
US12460173utility2025
Control of Cell Growth Through a Temperature Feedback Loop
0 cites
US12454531utility2025
Substituted Piperazine Derivatives Useful as T Cell Activators
0 cites
US12448395utility2025
Substituted Bicyclic Heteroaryl Compounds
0 cites
US12441711utility2025
Compounds and Their Use for Treatment of Hemoglobinopathies
0 cites
US12435057utility2025
Triazole Carboxylic Acids as LPA Antagonists
0 cites
US12435136utility2025
Antibodies Binding to ILT4
0 cites
US12428421utility2025
Pyrimidinones as Factor XIA Inhibitors
0 cites
US12428430utility2025
Oxabicyclo Acids as LPA Antagonists
0 cites
US12421195utility2025
Amorphous and Crystalline Forms of IDO Inhibitors
0 cites
US12421230utility2025
Tricyclic Heteroaryl Compounds Useful as IRAK4 Inhibitors
0 cites
US12419953utility2025
Methods of Treatment or Prevention of Immune Responses and Inflammatory Diseases with Antagonistic CD40 Monoclonal Antibodies
0 cites
US12421278utility2025
Immunomodulators
0 cites
US12409223utility2025
Antagonistic CD40 Monoclonal Antibodies and Uses Thereof
0 cites
US12410457utility2025
Use of Rosmarinic Acid in Cell Bioproduction
0 cites
US12403174utility2025
Immunomodulators
0 cites
US12404239utility2025
Modulators of BCL6 as Ligand Directed Degraders
0 cites
US12404274utility2025
Macrocycles as Factor Xia Inhibitors
0 cites
US12403254utility2025
System for Interrogating Serially-connected Drug Modules in a Combinatorial Drug Delivery Device
0 cites

← PreviousPage 3 of 13Next →